MARGINAL ZONE LYMPHOMA (MZL)
Clinical trials for MARGINAL ZONE LYMPHOMA (MZL) explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA (MZL) trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA (MZL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for patients with aggressive lymphoma that Won't quit
Disease control OngoingThis trial is testing a new drug called epcoritamab in people with B-cell lymphoma that has come back or stopped responding to standard treatments. The main goals are to find a safe and effective dose, understand the side effects, and see how well the drug works to control the ca…
Matched conditions: MARGINAL ZONE LYMPHOMA (MZL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
Scientists test gentler combo to tame lymphoma
Disease control OngoingThis study is testing a new combination of drugs for people with a type of blood cancer called marginal zone lymphoma who have not yet received treatment. The goal is to see if this regimen can effectively control the disease while causing fewer severe side effects than current s…
Matched conditions: MARGINAL ZONE LYMPHOMA (MZL)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy aims to zap eye cancer with fewer side effects
Disease control OngoingThis study is testing if a new drug, orelabrutinib, works better and is safer when combined with either very low-dose radiation or another drug called rituximab for a rare, slow-growing lymphoma around the eye. It involves 39 adults with early-stage disease who haven't had prior …
Matched conditions: MARGINAL ZONE LYMPHOMA (MZL)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Study asks: does 'Watching' cancer cause more worry than treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how the 'watch and wait' approach affects the quality of life for Korean patients with slow-growing lymphomas. Researchers will survey 250 patients who are currently monitoring their cancer without active treatment to measure their anxiety, distress,…
Matched conditions: MARGINAL ZONE LYMPHOMA (MZL)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:23 UTC